Synthesis of a β-tetrapeptide analog as a mother compound for the development of matrix metalloproteinase-2-imaging agents

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 3, 2008, Pages 260-265

  Mukai, Takahiro ^a   Suganuma, Noriko ^a   Soejima, Kenta ^a   Sasaki, Junichi ^a   Yamamoto, Fumihiko ^a   Maeda, Minoru ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

tetrapeptide; Inhibitor; Matrix metalloproteinase 2; Radiopharmaceutical

Indexed keywords

ALCOHOL DERIVATIVE; ALPHA AMINO ACID; BETA AMINO ACID; CYANIDE; CYCLOPEPTIDE; CYSTEINE; ESTER DERIVATIVE; GELATINASE A; GLYCINE; HISTIDINE; LEUCINE; PHENYLALANINE; TETRAPEPTIDE; THREONINE; TRYPTOPHAN;

ARTICLE; BIOTRANSFORMATION; DRUG ACCUMULATION; DRUG DESIGN; DRUG POTENCY; DRUG SELECTIVITY; DRUG STABILITY; DRUG SYNTHESIS; DRUG TUMOR LEVEL; ENZYME ASSAY; ENZYME INHIBITION; HYDROLYSIS; IMAGING SYSTEM; IN VIVO STUDY; ISOTOPE LABELING; PERMEABILITY; TARGET ORGAN;

DRUG DESIGN; GELATIN; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MATRIX METALLOPROTEINASE 2; PEPTIDES; PEPTIDES, CYCLIC; PROTEASE INHIBITORS; RADIOPHARMACEUTICALS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 41549134637     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.260     Document Type: Article

References (25)

1. Nagase H., Woessner J. F., Jr., J. Biol. Chem., 274, 21491-21494 (1999).
2. Sternlicht M. D., Werb Z., Annu. Rev. Cell Dev. Biol., 17, 463-516 (2001).
3. Van de Wiele C., Oltenfreiter R., Cancer Biother. Radiopharm., 21, 409-417 (2006).
4. Hartung D., Schäfers M., Fujimoto S., Levkau B., Narula N., Kopka K., Virmani R., Reutelingsperger C., Hofstra L., Kolodgie F. D., Petrov A., Narula J., Eur. J. Nucl. Med. Mol. Imaging, 34, S1-S8 (2007).
5. Librach C. L., Werb Z., Fitzgerald M. L., Chiu K., Corwin N. M., Esteves R. A., Grobelny D., Galardy R., Damsky C. H., Fisher S. J., J. Cell Biol., 113, 437-449 (1991).
6. Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H., Itohara S., Cancer Res., 58, 1048-1051 (1998).
7. Galis Z. S., Sukhova G. K., Lark M. W., Libby P., J. Clin. Invest., 94, 2493-2503 (1994).
8. Kuzuya M., Nakamura K., Sasaki T., Cheng X. W., Itohara S., Iguchi A., Arterioscler. Thromb. Vasc. Biol., 26, 1120-1125 (2006).
9. Kuhnast B., Bodenstein C., Haubner R., Wester H. J., Senekowitsch- Schmidtke R., Schwaiger M., Weber W. A., Nucl. Med. Biol., 31, 337-344 (2004).
10. Sprague J. E., Li W. P., Liang K., Achilefu S., Anderson C. J., Nucl. Med. Biol., 33, 227-237 (2006).
11. Hanaoka H., Mukai T., Habashita S., Asano D., Ogawa K., Kuroda Y., Akizawa H., Iida Y., Endo K., Saga T., Saji H., Nucl. Med. Biol., 34, 503-510 (2007).
12. Koivunen E., Arap W., Valtanen H., Rainisalo A., Medina O. P., Heikkilä P., Kantor C., Gahmberg C. G., Salo T., Konttinen Y. T., Sorsa T., Ruoslahti E., Pasqualini R., Nat. Biotechnol., 17, 768-774 (1999).
13. Cheng R. P., Gellman S. H., DeGrado W. F., Chem. Rev., 101, 3219-3232 (2001).
14. Steer D. L., Lew R. A., Perlmutter P., Smith A. I., Aguilar M. I., Curr. Med. Chem., 9, 811-822 (2002).
15. Seebach D., Beck A. K., Bierbaum D. J., Chem. Biodivers., 1, 1111-1239 (2004).
16. Gademann K., Kimmerlin T., Hoyer D., Seebach D., J. Med. Chem., 44, 2460-2468 (2001).
17. Podlech J., Seebach D., Angew. Chem. Int. Ed. Engl., 34, 471-472 (1995).
18. Guichard G., Abele S., Seebach D., Helv. Chim. Acta, 81, 187-206 (1998).
19. Sutton P. W., Bradley A., Elsegood M. R. J., Farràs J., Jackson R. F. W., Romea P., Urpí F., Vilarrasa J., Tetrahedron Lett., 40, 2629-2632 (1999).
20. Farràs J., Ginesta X., Sutton P. W., Taltavull J., Egeler F., Romea P., Urpí F., Vilarrasa J., Tetrahedron, 57, 7665-7674 (2001).
21. Lee V., Newman M. S., Org. Synth., 50, 77 (1970).
22. Kumar A., Ghilagaber S., Knight J., Wyatt P. B., Tetrahedron Lett., 43, 6991-6994 (2002).
23. Wester H. J., Kessler H., J. Nucl. Med., 46, 1940-1945 (2005).
24. Liu S., Mol. Pharm., 3, 472-487 (2006).
25. Wu Y., Zhang X., Xiong Z., Cheng Z., Fisher D. R., Liu S., Gambhir S. S., Chen X., J. Nucl. Med., 46, 1707-1718 (2005).